STOCK TITAN

Vita Coco (NASDAQ: COCO) CEO sells 29,456 shares after option exercise

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Vita Coco Company, Inc. CEO Martin Roper exercised stock options and sold the resulting shares. He exercised options for 29,456 shares of common stock at an exercise price of $10.178 per share, then sold 29,456 shares in open-market trades at weighted average prices around $50-$51.10 under a Rule 10b5-1 trading plan. After these transactions, he directly holds 298,484 common shares, alongside additional indirect holdings through family trusts and his spouse.

Positive

  • None.

Negative

  • None.
Insider Roper Martin
Role Chief Executive Officer
Sold 29,456 shs ($1.48M)
Type Security Shares Price Value
Exercise Non-Qualified Stock Option (Right to Buy) 4,456 $0.00 --
Exercise Common Stock 4,456 $10.178 $45K
Sale Common Stock 4,456 $50.549 $225K
Exercise Non-Qualified Stock Option (Right to Buy) 25,000 $0.00 --
Exercise Common Stock 25,000 $10.178 $254K
Sale Common Stock 25,000 $50.107 $1.25M
holding Non-Qualified Stock Option (Right to Buy) -- -- --
holding Non-Qualified Stock Option (Right to Buy) -- -- --
holding Non-Qualified Stock Option (Right to Buy) -- -- --
holding Non-Qualified Stock Option (Right to Buy) -- -- --
holding Non-Qualified Stock Option (Right to Buy) -- -- --
holding Non-Qualified Stock Option (Right to Buy) -- -- --
holding Common Stock -- -- --
holding Common Stock -- -- --
holding Common Stock -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Non-Qualified Stock Option (Right to Buy) — 500,214 shares (Direct); Common Stock — 302,940 shares (Direct); Common Stock — 215,631 shares (Indirect, by Chris Roper FT)
Footnotes (1)
  1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.15, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $51.10, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. These shares are held by the Christopher G. Roper Exempt Family Trust. These shares are held by the Peter S. Roper Exempt Family Trust. These shares are held by the Thomas L. Roper Exempt Family Trust. The stock option is fully vested and currently exercisable. The stock option vests in four equal annual installments beginning on November 27, 2022. The stock option vests in four equal annual installments beginning on March 10, 2024. The stock option vests in four equal annual installments beginning on March 4, 2025. The stock option vests in four equal annual installments beginning on March 3, 2026.
Options exercised 29,456 shares Non-qualified stock options exercised at $10.178 per share
Exercise price $10.178/share Strike price for options converted into common stock
Shares sold 29,456 shares Open-market sales on April 10 and April 13, 2026
Sale prices $50.107 and $50.549/share Weighted average prices across multiple sale transactions
Direct holdings after trades 298,484 shares Common stock directly owned following the reported transactions
Indirect family trust holdings 647,893 shares Three exempt family trusts: 215,631, 216,131 and 216,131 shares
Spouse indirect holdings 41,200 shares Common stock held indirectly by spouse
Largest remaining option block 298,507 underlying shares Non-qualified options at $15.00 expiring October 21, 2031
Non-Qualified Stock Option financial
"security_title: "Non-Qualified Stock Option (Right to Buy)""
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.
Rule 10b5-1 trading plan financial
"The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Exempt Family Trust financial
"These shares are held by the Christopher G. Roper Exempt Family Trust."
open-market sale financial
"transaction_action: "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
stock option vests in four equal annual installments financial
"The stock option vests in four equal annual installments beginning on March 3, 2026."
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Roper Martin

(Last)(First)(Middle)
111 5TH AVENUE
2ND FLOOR

(Street)
NEW YORK NEW YORK 10003

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chief Executive Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/10/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock04/10/2026M25,000A$10.178323,484D
Common Stock04/10/2026S(1)25,000D$50.107(2)298,484D
Common Stock04/13/2026M4,456A$10.178302,940D
Common Stock04/13/2026S(1)4,456D$50.549(3)298,484D
Common Stock215,631Iby Chris Roper FT(4)
Common Stock216,131Iby Peter Roper FT(5)
Common Stock216,131Iby Thomas Roper FT(6)
Common Stock41,200Iby Spouse
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Non-Qualified Stock Option (Right to Buy)$10.17804/10/2026M25,000 (7)09/19/2029Common Stock25,000$0504,670D
Non-Qualified Stock Option (Right to Buy)$10.17804/13/2026M4,456 (7)09/19/2029Common Stock4,456$0500,214D
Non-Qualified Stock Option (Right to Buy)$10.178 (7)01/11/2031Common Stock40,95040,950D
Non-Qualified Stock Option (Right to Buy)$15 (8)10/21/2031Common Stock298,507298,507D
Non-Qualified Stock Option (Right to Buy)$16.91 (9)03/10/2033Common Stock46,87546,875D
Non-Qualified Stock Option (Right to Buy)$16.91 (7)03/10/2033Common Stock185,133185,133D
Non-Qualified Stock Option (Right to Buy)$26.18 (10)03/04/2034Common Stock62,74362,743D
Non-Qualified Stock Option (Right to Buy)$32.78 (11)03/03/2035Common Stock70,71570,715D
Explanation of Responses:
1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.15, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $51.10, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
4. These shares are held by the Christopher G. Roper Exempt Family Trust.
5. These shares are held by the Peter S. Roper Exempt Family Trust.
6. These shares are held by the Thomas L. Roper Exempt Family Trust.
7. The stock option is fully vested and currently exercisable.
8. The stock option vests in four equal annual installments beginning on November 27, 2022.
9. The stock option vests in four equal annual installments beginning on March 10, 2024.
10. The stock option vests in four equal annual installments beginning on March 4, 2025.
11. The stock option vests in four equal annual installments beginning on March 3, 2026.
/s/ Alison Klein, attorney-in-fact for Martin Roper04/14/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Vita Coco (COCO) CEO Martin Roper report in this Form 4?

Martin Roper reported exercising stock options and selling the resulting Vita Coco common shares. He exercised 29,456 options at an exercise price of $10.178 per share, then sold 29,456 shares in open-market transactions under a Rule 10b5-1 trading plan.

How many Vita Coco (COCO) shares did the CEO sell and at what prices?

Martin Roper sold 29,456 Vita Coco common shares. The reported weighted average sale prices were $50.107 and $50.549 per share, across multiple trades executed in ranges from $50.00 to $51.10, as disclosed in the filing’s footnotes.

How many Vita Coco (COCO) shares does the CEO own after these transactions?

After the reported transactions, Martin Roper directly owns 298,484 Vita Coco common shares. The filing also shows indirect holdings of 215,631, 216,131 and 216,131 shares via three exempt family trusts, plus 41,200 shares held by his spouse, in addition to his direct position.

Were the Vita Coco (COCO) CEO’s share sales made under a Rule 10b5-1 plan?

Yes. The filing states the sales of Vita Coco common stock were effected under a Rule 10b5-1 trading plan. Such plans are pre-arranged programs that schedule trades in advance, which can make the timing of the transactions more routine from a governance perspective.

What stock options does the Vita Coco (COCO) CEO still hold after exercising some?

The filing lists several remaining non-qualified stock options held directly by Martin Roper. These include options over 40,950 shares at $10.178, 298,507 shares at $15.00, 232,008 shares at $16.910, 62,743 shares at $26.18, and 70,715 shares at $32.78, with expirations between 2031 and 2035.

What pattern do the Vita Coco (COCO) CEO’s Form 4 transactions show?

The Form 4 shows an exercise-and-sell pattern. Martin Roper exercised options for 29,456 shares at $10.178 per share and sold the same number of shares around $50-$51.10. He retains a substantial direct and indirect equity stake plus significant unexercised stock options.